Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms
Over 75 kinase inhibitors (KIs) have been approved for the treatment of various cancers. KIs are orally administrated but mostly lack pediatric age-appropriate dosage forms or instructions for dose manipulation. This is highly problematic for clinical practice in pediatric oncology, as flexible oral...
Saved in:
Main Authors: | Emma C. Bernsen (Author), Valery J. Hogenes (Author), Bastiaan Nuijen (Author), Lidwien M. Hanff (Author), Alwin D. R. Huitema (Author), Meta H. M. Diekstra (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice
by: Raffaele Simeoli, et al.
Published: (2022) -
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
by: Emma C. Bernsen, et al.
Published: (2020) -
Formulation of Azithromycin Suspension as an Oral Dosage Form
by: Saba H. Jaber, et al.
Published: (2017) -
Formulation of Azithromycin Suspension as an Oral Dosage Form
by: Saba H. Jaber, et al.
Published: (2017) -
Formulation of Tinidazole as an Oral Suspension Dosage Form
by: Lubna A. Sabri, et al.
Published: (2013)